Medicines By Design

Learn More

Recent Press Releases

February 22, 2021: Viridian Therapeutics to Present at Three Upcoming Investor Conferences
January 19, 2021: miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team
December 17, 2020: miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease
November 10, 2020: miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
October 28, 2020: miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.